Engers; David A.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Engers; David A..The latest application filed is for "crystalline compounds".
- Engers; David A. - West Lafayette IN
- Engers; David A. - Collegeville PA
| Patent | Date |
|---|---|
| Crystalline compounds Grant 11,299,458 - McKinney , et al. April 12, 2 | 2022-04-12 |
| Crystalline Compounds App 20210198198 - MCKINNEY; Anthony Alexander ; et al. | 2021-07-01 |
| Crystalline compounds Grant 10,800,740 - McKinney , et al. October 13, 2 | 2020-10-13 |
| Crystalline Compounds App 20200039934 - MCKINNEY; Anthony Alexander ; et al. | 2020-02-06 |
| Crystalline compounds Grant 10,280,141 - McKinney , et al. | 2019-05-07 |
| Crystalline Compounds App 20180194726 - MCKINNEY; Anthony Alexander ; et al. | 2018-07-12 |
| Crystalline compounds Grant 9,856,217 - McKinney , et al. January 2, 2 | 2018-01-02 |
| Crystalline Compounds App 20170334850 - MCKINNEY; Anthony Alexander ; et al. | 2017-11-23 |
| Crystalline compounds Grant 9,708,261 - McKinney , et al. July 18, 2 | 2017-07-18 |
| Crystalline Compounds App 20160368871 - MCKINNEY; Anthony Alexander ; et al. | 2016-12-22 |
| Solid Dispersions Of Amorphous Paroxetine Mesylate App 20160136148 - Engers; David A. ; et al. | 2016-05-19 |
| Solid dispersions of amorphous paroxetine mesylate Grant 9,211,290 - Engers , et al. December 15, 2 | 2015-12-15 |
| Solid Dispersions Of Amorphous Paroxetine Mesylate App 20140187582 - ENGERS; David A. ; et al. | 2014-07-03 |
| Methods of treating mammals using nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors Grant 6,221,400 - Liversidge , et al. April 24, 2 | 2001-04-24 |
| Methods of making nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers Grant 6,068,858 - Liversidge , et al. May 30, 2 | 2000-05-30 |
| Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers Grant 6,045,829 - Liversidge , et al. April 4, 2 | 2000-04-04 |
| Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids Grant 5,571,536 - Eickhoff , et al. November 5, 1 | 1996-11-05 |
| Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids Grant 5,560,931 - Eickhoff , et al. October 1, 1 | 1996-10-01 |
| Nanoparticulate nsaid compositions Grant 5,518,738 - Eickhoff , et al. May 21, 1 | 1996-05-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 